Clinical Trial Update: A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating the safety and efficacy of AND017 in patients with beta-thalassemia, currently recruiting. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: β -Thalassemia | Phase 2 | Status: RECRUITING